Physician profile
Jon D Speed
NPI 1720403173
$1,751.78
in general payments reported to CMS, 2019-2025
15 companies · $600 in 2025
The $600 reported for 2025 was more than what 97% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $153 · 2023: $492 · 2024: $507 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,598.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $820.01 | 2022-2025 | Entyvio, Eohilia, Gattex |
| Qol Medical, LLC | $191.62 | 2023-2025 | Sucraid, Sucraid |
| Braintree Laboratories, INC. | $179.98 | 2022-2025 | Sutab, Suflave |
| Regeneron Healthcare Solutions, INC. | $149.13 | 2023-2025 | Dupixent |
| Trevena, INC. | $100.00 | 2023 | Olinvyk |
| Ardelyx, INC. | $81.20 | 2023-2025 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $47.40 | 2022-2024 | Relistor, Trulance |
| Janssen Biotech, INC. | $38.44 | 2023 | Simponi Aria, Remicade, Simponi |
| Aimmune Therapeutics, INC. | $35.42 | 2025 | Vowst, Zenpep |
| Abbvie INC. | $27.92 | 2025 | |
| Lilly USA, LLC | $19.31 | 2025 | Omvoh |
| Redhill Biopharma INC. | $17.97 | 2022 | |
| Ironwood Pharmaceuticals, INC | $16.08 | 2023 | Linzess |
| Pacira Pharmaceuticals Incorporated | $13.80 | 2022 | |
| Azurity Pharmaceuticals, INC. | $13.50 | 2025 | Suflave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Speed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.